@Grannell_ James Larkin has also shared examples of good practice before, e.g. organisations who don't take funding from pharmaceutical companies, incl College of Psychiatrists of Ireland https://t.co/z40UqFMsq5
RT @FrankMoriarty: Delighted that our study led by @LarkinJames published in @BJGPOpen was among the top 10 most read papers for 2021!
Delighted that our study led by @LarkinJames published in @BJGPOpen was among the top 10 most read papers for 2021!
RT @susanmsmith: Great impact @LarkinJames
RT @susanmsmith: Great impact @LarkinJames
RT @BJGPOpen: ⭐️No 7 | BJGP Open Top Ten 2021⭐️ Pens, post-its, lunches … What do GPs really think of their relationship with the pharmac…
Great impact @LarkinJames
RT @BJGPOpen: ⭐️No 7 | BJGP Open Top Ten 2021⭐️ Pens, post-its, lunches … What do GPs really think of their relationship with the pharmac…
“On a personal level, I always felt very uncomfortable seeing medical reps, the reason I probably saw them was because I didn’t want to be different or do something differently to the other GPs”
RT @BJGPOpen: ⭐️No 7 | BJGP Open Top Ten 2021⭐️ Pens, post-its, lunches … What do GPs really think of their relationship with the pharmac…
⭐️No 7 | BJGP Open Top Ten 2021⭐️ Pens, post-its, lunches … What do GPs really think of their relationship with the pharmaceutical industry? ➡️https://t.co/LZXeK7DQBq @LarkinJames @susanmsmith @FrankMoriarty @DaveByrneDB https://t.co/EqWS7HmSq7
GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study | BJGP Open https://t.co/PXoHrBAe1S
RT @MaritaHennessy: Always good to hear @LarkinJames talk abt industry payments to health professionals/healthcare orgs #DisclosureIsNotE…
This work is so NB We need to have more (honest) conversations in Ireland about acceptability of industry funding - esp in #PublicHealth #HealthServices #PPI #CPD Uncomfortable & confronting, but completely necessary for #PublicGood #COI #CDoH #Dis
RT @MaritaHennessy: Always good to hear @LarkinJames talk abt industry payments to health professionals/healthcare orgs #DisclosureIsNotE…
Always good to hear @LarkinJames talk abt industry payments to health professionals/healthcare orgs #DisclosureIsNotEnough-but we're not even doing that well enough 🇮🇪 Read more about this work: Payments-https://t.co/wqnRQBtsbk Perceptions-https://t.co/
RT @BJGPOpen: Pens, post-its, lunches, conference sponsorship… What do GPs really think of their relationship with the pharmaceutical indus…
RT @BJGPOpen: Pens, post-its, lunches, conference sponsorship… What do GPs really think of their relationship with the pharmaceutical indus…
RT @BJGPOpen: Pens, post-its, lunches, conference sponsorship… What do GPs really think of their relationship with the pharmaceutical indus…
RT @BJGPOpen: Pens, post-its, lunches, conference sponsorship… What do GPs really think of their relationship with the pharmaceutical indus…
RT @BJGPOpen: Pens, post-its, lunches, conference sponsorship… What do GPs really think of their relationship with the pharmaceutical indus…
Pens, post-its, lunches, conference sponsorship… What do GPs really think of their relationship with the pharmaceutical industry? ➡️https://t.co/LZXeK7DQBq @LarkinJames @susanmsmith @FrankMoriarty @DaveByrneDB #GPs https://t.co/sAphwEgr5r
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @susanmsmith: Well led on this @LarkinJames. Still lots of debate and variation in opinion on our interactions with Pharma despite moun…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @susanmsmith: Well led on this @LarkinJames. Still lots of debate and variation in opinion on our interactions with Pharma despite moun…
Well led on this @LarkinJames. Still lots of debate and variation in opinion on our interactions with Pharma despite mounting evidence that it does influence prescribing and why would they do it if it didn't? Pros and cons?
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
Very important paper. Well done @LarkinJames @susanmsmith @FrankMoriarty and all the team.
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
RT @LarkinJames: We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting wit…
We've published a new @BJGPOpen study: https://t.co/uEKiYNVJKG We sought to understand GPs’ experience of interacting with the pharmaceutical industry and explore their perceptions of how this interaction impacts on general practice We're very grateful to